Ornopia, Shanlee .

HRN: 28-69-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/13/2026
03/20/2026
IV
410mg
Q6h
T/C Bacterial Skin Infection
Checking Initial Appropriateness 
03/14/2026
MUPIROCIN 2%, 15G (TUBE)
03/14/2026
03/20/2026
TOPICAL
2%
BID
Impetigo
Checking Initial Appropriateness 
03/17/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
03/17/2026
03/24/2026
PO
3ml
BID
Impetigo
Checking Initial Appropriateness 
03/17/2026
MUPIROCIN 2%, 15G (TUBE)
03/17/2026
03/27/2026
TOPICAL
On Affected Site
TID
Impetigo
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: